During the past decade, CH Cahors conducted 31 clinical trials. In the 10-year time frame, 31 clinical trials started and 1 clinical trials were completed, i.e. on average, 3.2% percent of trials that started reached the finish line to date. In the past 5 years, 15 clinical trials started and 1 clinical trials were completed. i.e. 6.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "CH Cahors" #1 sponsor was "Intergroupe Francophone de Cancerologie Thoracique" with 10 trials, followed by "Federation Francophone de Cancerologie Digestive" with 4 trials sponsored, "University Hospital, Toulouse" with 4 trials sponsored, "Pfizer" with 3 trials sponsored and "UNICANCER" with 3 trials sponsored. Other sponsors include 19 different institutions and companies that sponsored additional 23 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "CH Cahors" #1 collaborator was "ANRS, Emerging Infectious Diseases" with 1 trials as a collaborator, "Agence Régionale de la Santé - Midi Pyrénées" with 1 trials as a collaborator, "Amgen" with 1 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator and "Breast International Group" with 1 trials as a collaborator. Other collaborators include 20 different institutions and companies that were collaborators in the rest 30 trials.

According to Clinical.Site data, the most researched conditions in "CH Cahors" are "Metastatic Colorectal Cancer" (3 trials), "Colorectal Cancer" (2 trials), "Rheumatoid Arthritis" (2 trials), "ALK Gene Mutation" (1 trials) and "ALK Gene Rearrangement Positive" (1 trials). Many other conditions were trialed in "CH Cahors" in a lesser frequency.

Most popular intervention types in "CH Cahors" are "Drug" (21 trials), "Other" (11 trials), "Biological" (3 trials), "Device" (3 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Gemcitabine" (2 trials), "Pemetrexed" (2 trials), "Tofacitinib" (2 trials), "placebo" (2 trials) and "2 post-mortem transcutaneous lung biopsies (1 anterior ; 1 posterior) using anatomical landmarks" (1 trials). Other intervention names were less common.

The vast majority of trials in "CH Cahors" are 42 trials for "All" genders and 6 trials for "Female" genders.

Currently, there are NaN active trials in "CH Cahors". 1 are not yet recruiting, 11 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 29 completed trials in CH Cahors, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in CH Cahors, 0 "Phase 1" clinical trials were conducted, 10 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 6 trials that are defined as “Not Applicable".